Literature DB >> 12693087

[Limited tuberculin screening participation amongst travellers to countries with high tuberculosis incidence; reason to consider BCG vaccination for some travellers].

F G J Cobelens1, E W E Draayer-Jansen, J C H M Schepp-Beelen, P J H J van Gerven, R J van Kessel, H van Deutekom.   

Abstract

OBJECTIVE: To determine the compliance amongst Dutch travellers to high tuberculosis-incidence countries with a screening procedure involving a tuberculin skin test before and after the trip.
DESIGN: Prospective study.
METHOD: Nine hundred and eighty-eight tuberculin-negative Dutch people who travelled to high tuberculosis-incidence countries for 3 to 12 months were studied for their compliance with an advised screening procedure of repeat tuberculin skin testing 2 to 4 months after return. At 2 of the 4 participating health services, data were also collected on extra calls made and the pertinent time investments.
RESULTS: Five hundred and ninety-nine travellers (61%) were compliant with the screening procedure. Of those for whom the data was available (n = 417), 33% (98/300) of the compliant travellers required extra calls. These took an average of 30 min per extra traveller tested as a result. Compliance varied according to health service and was better amongst travellers to Africa. In addition, non-compliance was independently associated with male sex, work being the main travel purpose, and an undecided duration of travel on departure.
CONCLUSIONS: Compliance of Dutch travellers with tuberculin skin-test screening is limited, particularly if no extra calls are issued. Bacillus Calmette-Guérin vaccination appears to be preferable for travellers with undecided travel duration and persons travelling for work on a frequent basis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12693087

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  2 in total

1.  The Use of Interferon-γ Release Assays for Tuberculosis Screening in International Travelers.

Authors:  Ludwig Apers; Cédric Yansouni; Patrick Soentjens; Marc Vekemans; Emmanuel Bottieau
Journal:  Curr Infect Dis Rep       Date:  2011-06       Impact factor: 3.725

2.  Screening travellers to high-endemic countries for infection with Mycobacterium tuberculosis using interferon gamma release assay; a prospective study.

Authors:  Floor Elfrink; Anneke van den Hoek; Marlies E Mensen; Gerard J B Sonder
Journal:  BMC Infect Dis       Date:  2014-09-23       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.